BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 17394696)

  • 1. Community-wide INH treatment of latent TB infection in a BCG-vaccinated population: experience in rural Taiwan.
    Bowerman RJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):470-2. PubMed ID: 17394696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan.
    Bowerman RJ
    Int J Tuberc Lung Dis; 2004 Oct; 8(10):1228-33. PubMed ID: 15527155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases.
    Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL
    Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(30):685-7. PubMed ID: 10947056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
    Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
    Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
    Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis contact investigation in a rural state.
    Webb RM; Holcombe M; Pearson MM
    Int J Tuberc Lung Dis; 2003 Dec; 7(12 Suppl 3):S353-7. PubMed ID: 14677822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of Mycobacterium tuberculosis associated with failed completion of treatment for latent tuberculosis infection--Chickasaw County, Mississippi, June 1999-March 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(11):222-4. PubMed ID: 12665113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis prevention for non-US-born pregnant women.
    Sackoff JE; Pfeiffer MR; Driver CR; Streett LS; Munsiff SS; DeHovitz JA
    Am J Obstet Gynecol; 2006 Feb; 194(2):451-6. PubMed ID: 16458645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
    Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
    Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.
    Higuchi K; Harada N; Mori T
    Respirology; 2008 May; 13(3):468-72. PubMed ID: 18399875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance to treatment of latent tuberculosis infection in a region of Israel.
    Bibi H; Weiler-Ravell D; Shoseyov D; Feigin I; Arbelli Y; Chemtob D
    Isr Med Assoc J; 2002 Jan; 4(1):13-6. PubMed ID: 11802301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Latent tuberculosis infection: diagnosis and treatment].
    Bendayan D; Raz M; Kramer MR
    Harefuah; 2002 Mar; 141(3):233-6, 316. PubMed ID: 11944212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City.
    Anger HA; Proops D; Harris TG; Li J; Kreiswirth BN; Shashkina E; Ahuja SD
    Clin Infect Dis; 2012 May; 54(9):1287-95. PubMed ID: 22412056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculin reactivity in adults after 50 years of universal bacille Calmette-Guerin vaccination in Taiwan.
    Yeh YP; Luh DL; Chang SH; Suo J; Chang HJ; Chen TH
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):509-16. PubMed ID: 15910894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of repeated QFT-2G checkings at two-year interval and their comparison with TST results introduced into infection control program for staffs working at a hospital with isolation wards for tuberculosis].
    Nakajima Y; Ogata H; Yoshiyama T; Mitarai S; Harada N; Higuchi K; Mori T
    Kekkaku; 2008 Jun; 83(6):445-50. PubMed ID: 18634448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.